150 related articles for article (PubMed ID: 31829748)
1. Advantages and limitations of amino acid PET for tracking therapy response in glioma patients.
Langen KJ; Heinzel A; Lohmann P; Mottaghy FM; Galldiks N
Expert Rev Neurother; 2020 Feb; 20(2):137-146. PubMed ID: 31829748
[No Abstract] [Full Text] [Related]
2. Combined PET/MRI in brain glioma imaging.
Almansory KO; Fraioli F
Br J Hosp Med (Lond); 2019 Jul; 80(7):380-386. PubMed ID: 31283392
[TBL] [Abstract][Full Text] [Related]
3. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
Galldiks N; Langen KJ
Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
[TBL] [Abstract][Full Text] [Related]
4. Comparison of O-(2-
Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
World Neurosurg; 2018 May; 113():e727-e737. PubMed ID: 29510293
[TBL] [Abstract][Full Text] [Related]
5. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
Albert NL; Weller M; Suchorska B; Galldiks N; Soffietti R; Kim MM; la Fougère C; Pope W; Law I; Arbizu J; Chamberlain MC; Vogelbaum M; Ellingson BM; Tonn JC
Neuro Oncol; 2016 Sep; 18(9):1199-208. PubMed ID: 27106405
[TBL] [Abstract][Full Text] [Related]
6. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
[TBL] [Abstract][Full Text] [Related]
7.
Suchorska B; Unterrainer M; Biczok A; Sosnova M; Forbrig R; Bartenstein P; Tonn JC; Albert NL; Kreth FW
J Neurooncol; 2018 Sep; 139(3):721-730. PubMed ID: 29948765
[TBL] [Abstract][Full Text] [Related]
8. Update on amino acid PET of brain tumours.
Langen KJ; Galldiks N
Curr Opin Neurol; 2018 Aug; 31(4):354-361. PubMed ID: 29952832
[TBL] [Abstract][Full Text] [Related]
9. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
10. Comparison of [
Shymanskaya A; Worthoff WA; Stoffels G; Lindemeyer J; Neumaier B; Lohmann P; Galldiks N; Langen KJ; Shah NJ
Mol Imaging Biol; 2020 Feb; 22(1):198-207. PubMed ID: 30989437
[TBL] [Abstract][Full Text] [Related]
11. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N
Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264
[TBL] [Abstract][Full Text] [Related]
12. PET and SPECT studies in children with hemispheric low-grade gliomas.
Juhász C; Bosnyák E
Childs Nerv Syst; 2016 Oct; 32(10):1823-32. PubMed ID: 27659825
[TBL] [Abstract][Full Text] [Related]
13. Role of amino-acid PET in high-grade gliomas: limitations and perspectives.
Verger A; Arbizu J; Law I
Q J Nucl Med Mol Imaging; 2018 Sep; 62(3):254-266. PubMed ID: 29696948
[TBL] [Abstract][Full Text] [Related]
14. Advances in neuro-oncology imaging.
Langen KJ; Galldiks N; Hattingen E; Shah NJ
Nat Rev Neurol; 2017 May; 13(5):279-289. PubMed ID: 28387340
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma.
Gandia P; Jaudet C; Everaert H; Heemskerk J; Vanbinst AM; de Mey J; Duerinck J; Neyns B; de Ridder M; Chatelut E; Concordet D
Clin Pharmacokinet; 2017 Aug; 56(8):953-961. PubMed ID: 27995528
[TBL] [Abstract][Full Text] [Related]
16. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of
He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
[TBL] [Abstract][Full Text] [Related]
19. Phase IIa clinical study of [
Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H
Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267
[TBL] [Abstract][Full Text] [Related]
20. Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors.
Riva M; Lopci E; Castellano A; Olivari L; Gallucci M; Pessina F; Fernandes B; Simonelli M; Navarria P; Grimaldi M; Rudà R; Castello A; Rossi M; Alfiero T; Soffietti R; Chiti A; Bello L
World Neurosurg; 2019 Jun; 126():e270-e280. PubMed ID: 30797926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]